Literature DB >> 24797000

The FDA and prescription pancreatic enzyme product cost.

Timothy B Gardner1, Jeffrey C Munson1, Nancy E Morden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24797000      PMCID： PMC4096660          DOI： 10.1038/ajg.2013.430

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Incentives for drug development--the curious case of colchicine.

Authors:  Aaron S Kesselheim; Daniel H Solomon
Journal:  N Engl J Med       Date:  2010-04-14       Impact factor: 91.245

2.  Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity.

Authors:  L Hendeles; A Dorf; A Stecenko; M Weinberger
Journal:  JAMA       Date:  1990-05-09       Impact factor: 56.272

Review 3.  Pancreatic enzyme products: digesting the changes.

Authors:  Christopher A Giuliano; Michelle L Dehoorne-Smith; Pramodini B Kale-Pradhan
Journal:  Ann Pharmacother       Date:  2011-05-03       Impact factor: 3.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.